European Organisation for
Research and Treatment of Cancer

Active for
60 years

Network of
3400+ scientists

Present in
50 countries

100+ studies
in follow-up

40+ ongoing
studies

260+ experts
in HQ

Latest news

  • EORTC Quality of Life measures integrated in CDISC

    EORTC Quality of Life measures integrated in CDISC

    20 Nov 2023

  • ATOM study

    EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

    7 Nov 2023

  • acute myeloid leukaemia publication

    Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

    31 Oct 2023

Projects

SPECTA

E²-RADIATE

RECIST

Latest publications

Upcoming events

  • EORTC Y-ECI QLG/LCG First Collaborative Webinar

    07 Dec - 07 Dec 2023

  • BGICC 2024

    Breast Gynecological & Immunooncology International Cancer Conference

    18 Jan - 19 Jan 2024

    Cairo

    • Past events

  • EORTC Gynecological cancer group

    EORTC Gynecological Cancer Group Autumn Meeting

    17 Nov - 17 Nov 2023

    Brussels, Belgium (hybrid)

  • ECI Leadership Programme

    Y-ECI LCG and Y-ECI ROSC Webinar – Session 2

    15 Nov - 15 Nov 2023

    Webinar

    • Highlights

    • Annual-Report-2022

      Publication of 2022 EORTC Annual Report

    • Manifesto - Illustration

      Manifesto

    • EORTC Practice Changing Trials

      Practice Changing Trials

    • EORTC Cancer Research Fund

      ECRF

      EORTC Cancer Research Fund